Immunotherapy advances in targeting pancreatic, prostate and kidney cancers
This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology.
Sharma, along with Jim Allison, Ph.D., chair of Immunology, leads the immunotherapy platform of MD Anderson’s Moon Shots Program™, a collaborative effort to accelerate the development of scientific discoveries into clinical advances that save patients’ lives.<...
Immunotherapy leader details ongoing expansion of cancer treatment's reach
In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...
Immunotherapy, liquid biopsy research among AACR highlights
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting, which...
Multiple surgeries may be unnecessary for some stage zero breast cancer patients
Patients with stage zero breast cancer, also known as ductal carcinoma in situ, who undergo breast-conserving surgery that results in narrow negative margins may not need additional surgeries if radiation therapy is performed, according to a recent analysis by MD Anderson researchers.
The study, led by Audree Tadros, M.D., and Henry Kuerer, M.D., Ph.D., of the Breast Surgical Oncology department, was conducted to clarify the benefits...
In the news: Hero doctors braved Harvey to reach patients
Hurricane Harvey brought with it unprecedented rainfall – 27 trillion gallons – and staggering destruction – 33 Texas counties declared federal...
MD Anderson cancer experts share discoveries at AACR Annual Meeting
A number of MD Anderson physicians and scientists chaired or co-chaired sessions and presented research, ranging from racial disparities in...
Global cancer prevention efforts support
World Cancer Day goals
World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...
New partnerships push innovative approaches to cancer treatment forward
In the modern world of biomedical research, collaborations between academic institutions and pharmaceutical and biotech companies have become...
Molecular testing used to find the best clinical trial for triple negative breast cancer patients
A new trial underway at MD Anderson may lead to new therapies for triple negative breast cancer.
Fifteen to 20% of breast cancers...
World Cancer Day reflects the daily mission of MD Anderson
Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed to...